PROGNOSTXHEALTH

Dead / Abandoned — Abandoned — no statement of use filed (as of 17 Feb 2025)

What this means for you

This application is over — abandoned 17 Feb 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
97542778
Mark type
Stylized text
Filed
10 Aug 2022
Published for opposition
21 Nov 2023
Abandoned
17 Feb 2025
Attorney of record
Monte L. Falcoff

Goods and services

  • Class 005 — Pharmaceuticals: diagnostic kits and instruments primarily comprised of immunological assays, antibodies and reagents for medical testing of diseases; testing apparatus and instruments being diagnostic kits for medical or research purposes primarily comprised of reagents for creating assays to capture and detect disease biomarkers
  • Class 009 — Scientific and electric apparatus: Computer hardware, recorded software, and control algorithms sold as a unit for determining medical risk-scores for prediabetes, diabetes, obesity, kidney disease, cardiovascular disease, hypertension, eye disease, dementia and Alzheimer's disease, neurodevelopmental disorders, and solid organ cancers including cancers of the gastrointestinal tract, kidney, lung, liver, pancreas, and bladder
  • Class 010 — Medical apparatus: diagnostic kits and instruments primarily comprised of a coated surface, a reagent and an immunoassay using antibodies or molecular probes for medical diagnosis of diseases and medical use; testing apparatus and instruments for medical purposes in the nature of a coated plate or other surface materials including but not limited to plastic, glass, or metals used to create assays to capture and detect disease biomarkers; Medical diagnostic and therapeutic apparatuses primarily comprised of antibody or antigen coated surfaces, reagents, immunoassays, computers, software and algorithms for determining medical risk-scores for prediabetes, diabetes, obesity, kidney disease, cardiovascular disease, hypertension, eye disease, dementia and Alzheimer's disease, neurodevelopmental disorders, and solid organ cancers including cancers of the gastrointestinal tract, kidney, lung, liver, pancreas, and bladder
  • Class 042 — Scientific and technological services: Biomedical research services; scientific laboratory services; providing reagent sample testing for others in the fields of medical diseases and medicine; Development of testing for kidney diseases in a laboratory setting; Medical and scientific research, namely, conducting clinical trials for others featuring clinical trial design, statistical evaluation, and execution; Scientific and medical research and consulting services featuring algorithms, artificial intelligence and machine learning development, evaluation and clinical utility; Scientific and medical research and consulting services featuring biostatistical support; Manufacturing services, namely, development of minimal viable products in the nature of medical diagnostic tests for others; consulting services related to laboratory developed testing procedures, strategy and execution in the field of medical diagnostics, medical tests and pharmaceutical research; Quality evaluation of clinical utility and applicability of innovative technologies in the medical field
  • Class 044 — Medical, beauty and agricultural services: Medical diagnostic services relating to diseases; medical testing services relating to the diagnosis and treatment of disease; Medical services, namely, administering reagent-based sample tests for others for diagnosis of diseases; Providing medical diagnostic information services for determining medical risk-scores for prediabetes, diabetes, obesity, kidney disease, cardiovascular disease, hypertension, eye disease, dementia and Alzheimer's disease, neurodevelopmental disorders, and solid organ cancers, cancers of the gastrointestinal tract, kidney, lung, liver, pancreas, and bladder using computers, software and algorithms

Owner

Prosecution history

  • 17 Feb 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 17 Feb 2025 — ABANDONMENT - NO USE STATEMENT FILED
  • 03 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 03 Oct 2024 — SOU EXTENSION 1 GRANTED
  • 09 Jul 2024 — SOU EXTENSION 1 FILED
  • 03 Oct 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 11 Jul 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 09 Jul 2024 — SOU TEAS EXTENSION RECEIVED
  • 16 Jan 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 05 Dec 2023 — ASSIGNED TO EXAMINER
  • 21 Nov 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 21 Nov 2023 — PUBLISHED FOR OPPOSITION
  • 01 Nov 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 13 Oct 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 13 Oct 2023 — EXAMINER'S AMENDMENT ENTERED

View this trademark record on Marksy